
Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity
Keywords: Acidosis; Carbonic anhydrase IX (CA IX); Cytotoxicity; Intracellular pH
Document Type: Research Article
Affiliations: 1: Julius-Bernstein-Institut für Physiologie, Universität Halle-Wittenberg, Halle, Germany 2: Klinik und Poliklinik für Strahlentherapie, Universität Halle-Wittenberg, Halle, Germany
Publication date: March 5, 2018
This article was made available online on June 19, 2017 as a Fast Track article with title: "Inhibition of Carbonic Anhydrase IX by Ureidosulfonamide Inhibitor U104 Reduces Prostate Cancer Cell Growth, But Does Not Modulate Daunorubicin or Cisplatin Cytotoxicity".
Formerly: Oncology Research Incorporating Anti-Cancer Drug Design
Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.From Volume 23, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics is Open Access under the terms of the Creative Commons CC BY-NC-ND license.